30/03/2023: Variation from Preliminary Final Report
17/03/2023: Notification regarding unquoted securities
17/03/2023: Notification of cessation of securities
02/03/2023: Results of General Meeting
02/03/2023: Section 708A Cleansing Notice
02/03/2023: Application for quotation of + securities
21/02/2023: Proposed Issue of Securities
03/02/2023: Notice of General Meeting
31/01/2023 Proposed issue of securities
31/01/2023: Q4 Review For Period ended 31 December 2022
09/01/2023: Chief Financial Officer Resignation
05/12/2022: Change of Director's Interest Notice
30/11/2022: Operational Update
25/11/2022: Proposed Restructure of Convertible Notes
16/11/2022: Director Resignation
16/11/2022: Final Director's Interest Notice
26/09/2022: Jayex Appoints Chief Executive Officer
30/06/2022: Financial Report for the half-year ended - 30 June 2022
29/08/2022: Variations to Convertible Note Deed & Loan Agreements
26/05/2022: Chairman's Address to Shareholders
26/05/2022: Results of Annual General Meeting
27/04/2022: Correction 31 March 2022 Appendix 4C
27/04/2022: March 2022 Quarterly Update and Appendix 4C
07/04/2022: Notification of cessation of +securities
31/03/2022: Variation from Preliminary Final Report
26/10/2021: Board Structure Update
22/09/2021: Change in substantial holding
22/09/2021: Change of Director's Interest Notices x3
22/09/2021: Application for quotation of securities - JTL
21/09/2021: Response to ASX Price Query
20/09/2021: Entitlement Offer Results
14/09/2021: ASIC Media Release
01/09/2021: Appendix 4D Half-Year Report
05/08/2021: Rights Issue Cleansing Notice under section 708AA(2)(f)
05/08/2021: Proposed issue of securities - JTL
05/08/2021: Equity Raising to Raise up to $1.83 million
30/07/2021: June 2021 Quarterly Activities Report & Appendix 4C
30/07/2021: Reinstatement to Official Quotation
30/07/2021: Jayex Technology agrees strategic investment into Brainworks Foundry, Inc.
28/07/2021: Suspension from Official Quotation
30/06/2021: Change of Director's Interest Notice
08/06/2021: Broker briefing investor webinar
8/05/2021: Change of Company Name and ASX Code
27/05/2021: Results of Annual General Meeting
27/05/2021: Chairman's Address to Shareholders
26/05//2021: AGM Attendance Protocols
24/05/2021: Proposed issue of Securities - JHL
24/05/2021: JHL Placement raising $0.57m
17/05/2021: Jayex Healthcare Limited Completes Divestment
10/05/2021: Variation to Jayex Healthcare Binding Term Sheet
07/05.2021: Partial repayment of Convertible Notes
04/05/2021: Quarterly review for the period ended 31 March 2021 and trading update
13/04/2021: Jayex divests Acute (hospital) queue management business
12/04/2021: JHL sub obtains Cultivation Licence for Medical Marijuana
08/04/2021: Notice of Annual General Meeting/Proxy Form
30/03/2021: Jayex subsidiary completes cannabis licensing inspection
12/03/2021: Appendix 4G and Corporate Governance Statement
26/02/2021: Appendix 4E Preliminary Final Report
29/01/2021: Quarterly review for the period ending 31 December 2020 and Trading Update
16/12/2020: Jayex Operating Update
09/12/2020: Response to ASX Price Query
09/11/2020: Amendment to 30 September 2020 Appendix 4C
29/10/2020: September 2020 Quarterly Update and Appendix 4C
14/10/2020: Change of Director's Interest Notice
13/10/2020: Cleansing Statement and Appendix 3G - Convertible Notes
01/10/2020: Change of Director's Interest Notice
01/10/2020: Results of General Meeting
07/09/2020: Section 708A Notice and Appendix 2A
02/09/2020: Proposed Issue of Securities
02/09/2020: Non-Executive Director Appointment
02/09/2020: Jayex Completes $700K Capital Raise
02/09/2020: Appendix 3X Initial Director's Interest Notice
28/08/2020: Appendix 4D and Half-year Financial Report
27/08/2020: Notice of General Meeting/Proxy Form
31/07/2020: 2019 Annual General Meeting
31/07/2020: Results of Annual General Meeting
31/07/2020: Proposed Convertible Note Issue and Debt Conversion
24/07/2020: Quarterly & half-year review for the period ended 30 June 2020 and business update
01/07/2020: Change of Director's Interest Notice
30/06/2020: Change of Director's Interest Notice
29/06/2020: Resignation of CEO and Managing Director
11/06/2020: Jayex signs Licence Agreement with Lifespot Health
04/06/2020: AGM Date and Director Nomination Closing Date
19/05/2020: JHL receives funding in form of COVID-19 support
28/04/2020: March 2020 Quarterly Update and Appendix 4C
16/04/2020: COVID-19 (Coronavirus Pandemic) Market Update - Correction
09/04/2020: COVID—19 (Coronavirus Pandemic) Market Update
25/03/2020: Defferal of Annual General Meeting
24/03/2020: Appendix 4G Corporate Governance Council Principles and Recommendations
04/03/2020: Section 708A Notice and Appendix 2A
28/02/2020: Notice under Section 708A(5)(e)of the Corporations Act 2001
28/02/2020: Appendix 4E Preliminary Final Report
10/02/2020: Response to ASX Appendix 4C query
22/01/2020: Jayex Technology Ltd enters joint venture with LYPHE Group
09/12/2019: Jayex enters Partnership with Microtech Group
06/12/2019: Final Director's Interest Notice
06/12/2019: Registration of Director
15/11/2019: Appendix 3Y Change of Director's Interest Notice
31/10/2019: Quarterly Cash Flow Report and Trading Update
13/09/2019: Change of share registry details
30/08/2019: Appendix 4D and Half-year Financial Report
26/07/2019: Appendix 4C Quarterly
22/07/2019: Mutual Termination on Consulting Contracts
12/06/2019: Change in Substantial Holding
03/06/2019: Section 708A Notice and Appendix 3B
31/05/2019: Response to ASX Price Query
24/05/2019: Results of Annual General Meeting
08/05/2019: NZ Medical Cannabis -Research Facility Approval
30/04/2019: Appendix 4C - Quarterly
24/04/2019: Annual Report to Shareholders
23/04/2019: Notice of Annual General Meeting/Proxy Form
08/04/2019: Change of Director's Interest Notice M. Boyd
08/04/2019: Change of Director's Interest Notice - Correction
02/04/2019: Change of Director's Interest Notice M. Boyd
28/03/2019: Apppendix 4G & 2018 Corporate Governance Statement
27/03/2019: Appendix 3Y Change of Director's Interest Notice
18/02/2019: Revised NZ Medical Cannabis and Technology Commercialisation Strategy
31/01/2019: Quarterly Cash Flow Report
29/10/2018: Appendix 4C - Quarterly Cash Flow Report
23/10/2018: Termination of License Agreement
25/07/2018: Appendix 4C - Quarterly
25/07/2018: Change of Director's Interest Notice
20/07/2018: Retraction of Announcement
14/07/2018: Section 708A Notice and Appendix 3B
10/07/2018: JHL executes Binding Licence Agreement with Medicann
19/06/2018: Appendix 3B New Issue Announcement
08/06/2018: Notice of Change of Interests of Substantial holder
08/06/2018: Notice of Change of Interests of Substantial holder
07/06/2018: Appendix 3Y Change of Director's Interest Notice
05/06/2018: Change of Principal Place of Business
05/06/2018: Appendix 3Y Change of Director's Interest Notice
05/06/2018: Appendix 3B New Issue Announcement
05/06/2018: Appendix 3Y Change of Director's Interest Notice
25/05/2018: 2018 AGM Presentation
25/05/2018: Results of Annual General Meeting 2018
23/04/2018: Notice of Annual General Meeting, Explanatory Statement and Proxy Form
27/02/2018: Appendix 4G & 2017 Corporate Governance Statement
27/02/2018: Appendix 4E and 2017 Annual Report
31/01/2018: Appendix 4C – quarterly
08/01/2018: Discontinuance of Legal Proceedings
01/12/2017: Release of Securities from Escrow
24/11/2017: Section 708A Notice and Appendix 3B
16/11/2017: Response to ASX Appendix 4C Query
31/10/2017: Appendix 4C – Quarterly
11/10/2017 : Loan Agreement (JHL)
02/10/2017 : Change of Director’s Interest Notice
26/09/2017 : Change of Director’s Interest Notice
22/09/2017 : Change of Director’s Interest Notice
22/08/2017 : Appendix 4D and Interim Financial Report
31/07/2017 : Appendix 4C – quarterly
03/07/2017 : Change of Director’s Interest Notice
03/07/2017 : Change of Director’s Interest Notice
24/05/2017 : Results of Annual General Meeting
24/05/2017 : 2017 AGM Presentation
24/05/2017 : Chief Executive Officer Appointment
23/05/2017 : Loan Facility Finalised
15/05/2017 : Change of Director’s Interest Notice
21/04/2017 : 2016 Annual Report to shareholders
21/04/2017 : Notice of Annual General Meeting/Proxy Form
28/02/2017 : Apppendix 4G & 2016 Corporate Governance Statement
28/02/2017 : Appendix 4E and 2016 Annual Report
31/01/2017 : Appendix 4C – Quarterly
12/01/2017 : Section 708A Notice and Appendix 3B
09/12/2016 : Change of Director’s Interest Notice
29/11/2016 : Jayex Healthcare wins four-year contract with Cohealth
31/10/2016 : Appendix 4C – quarterly
28/10/2016 : Change of Principal Place of Business
18/10/2016 : Section 708A Notice and Appendix 3B
30/09/2016 : Appendix 3B – Release of Escrow
29/09/2016 : Change of Director’s Interest Notice
22/09/2016 : Change of Director’s Interest Notice
22/09/2016 : Appendix 3B – Release of Escrow
14/09/2016 : Change of Director’s Interest Notice
06/09/2016 : Release of Securities from Escrow
31/08/2016 : First Half 2016 Results Review
31/08/2016 : Appendix 4D and Interim Financial Report
01/08/2016 : Resignation of Director
29/07/2016 : Appendix 4C – quarterly
13/07/2016 : Resignation of Director
20/06/2016 : Announcement Title: Section 708A Notice and Appendix 3B
24/05/2016 : Results of Annual General Meeting
24/05/2016 : 2015 AGM Presentation
17/05/2016 : Change of Director’s Interest Notice
11/05/2016 : Investor Presentation – May 2016
09/05/2016 : Change of Director’s Interest Notice
02/05/2016 : Appointuit – PKF Settlement
29/04/2016 : Appendix 4C – Quarterly Report
29/04/2016 : 2015 Annual Report to shareholders
22/04/2016 : JHL 2016 AGM NOM & Proxy form for Website
04/04/2016 : Change of Director’s Interest Notice
30/03/2016 : Securities Trading Policy – Updated
30/03/2016 : Apppendix 4G & 2015 Corporate Governance Statement
30/03/2016 : Full Year Statutory Accounts
24/03/2016 : Jayex UK – Port of Dover Contract Update
29/02/2016 : Appointuit Litigation
29/02/2016 : Preliminary Final Report – Appendix 4E
03/02/2016 : New Issue Announcement – Appendix 3B
29/01/2016 : Quarterly Cash Flow Report
15/01/2016 : Expansion into Allied Healthcare Key-Management Appointments
14/01/2016 : Appendix 3X – Initial Directors Interest Notice
18/12/2015 : Becoming a Substantial Holder – A Jain
17/12/2015 : Becoming a substantial holder – M Boyd
17/12/2015 : Becoming a substantial holder – Jayex Healthcare Limited
17/12/2015 : Initial Director’s Interest Notice – S Tanner
17/12/2015 : Initial Director’s Interest Notice – J Allinson
17/12/2015 : Initial Director’s Interest Notice – B Renwick
Terms of Use | Privacy Notice | Cookie Policy | Terms & Conditions © 2021 Jayex Technology Limited
Jayex ABN - 24 164 924 805 | Jayex NZBN - 9429046086440
© 2023 Jayex Technology Limited | Website by Blend
ASX Accouncements
Reports & Presentations
Corporate Governance
News